Evaluation of the use of non-invasive strategies in patients with respiratory failure by COVID-19
DOI:
https://doi.org/10.33233/fb.v24i1.5332Keywords:
respiratory failure, coronavirus, betacoronavirus, noninvasive ventilation, cannulaAbstract
Introduction: During the COVID-19 pandemic, it became necessary to use strategies in the treatment of patients with acute respiratory failure. Objective: To evaluate the use of non-invasive strategies in the outcome of patients with acute or chronic respiratory failure exacerbated by COVID-19. Methods: Observational and retrospective research through the collection of data from electronic medical records with patients submitted to the use of high-flow nasal cannula (HFNC) and/or non-invasive mechanical ventilation (NIV). Results: 81 patients, 70.4% (57) were male, aged 56.5 ± 14.6 years. 49.4% (40) of the individuals used CNAF and NIV, 9.9% (8) and 40.7% (33) only NIV or HFNC, respectively. The mean time of HFNC use was 4.4 ± 3.7 days and NIV was 2.7 ± 3.4 days. 53.1% (43) of the patients surveyed evolved to orotracheal intubation (OTI) and 40 (49.4%) died. Of these 22 were undergoing OTI. There was a statistical difference when comparing age between OTI and non-OTI groups, 60.5 ± 13.9 years vs 52.1 ± 14.2 years (p = 0.012), respectively. Conclusion: The use of NIV and/or HFNC can be considered as an alternative in the treatment of patients with COVID-19. However, several intrinsic and extrinsic factors to the patient still contribute to the high rate of OTI and mortality.
References
Thakur V, Ratho RK, Kumar P, Bhatia SM, Bora K, Mohi GK, et al. Multi-Organ involvement in COVID-19: beyond pulmonary manifestations. J Clin Med. 2021;446(10):1-19. doi: 10.3390/jcm10030446
World Health Organization. WHO Coronavirus (COVID-19) Dashboard [Internet]. [citado 2023 Jan 16]. Disponível em: https://covid19.who.int/
Guy T, Créac'hcadec A, Ricordel C, Salé A, Arnouat B, Bizec JL, et al. High-flow nasal oxygen: a safe, efficient treatment for COVID-19 patients not in an ICU. Eur Resp J. 2020;56(5):1-3. doi: 10.1183/13993003.01154-2020
Procopio G, Cancelliere A, Trecarichi EM, Mazzitelli M, Arrighi E, Perri G, et al. Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study. Ther Adv Resp Dis. 2020;14(9):1-10. doi: 10.1177/1753466620963016
Gupta A, Madhavan MV, Sehgal K, Nandini N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(6):1017-1032. doi: 10.1038/ s41591-020-0968-3
Raoof S, Nava S, Carpati C, Hill NS. High-flow, noninvasive ventilation and awake (Nonintubation) proning in patientes with coronavirus disease 2019 with respiratory failure. Chest. 2020;158(5):1992-2002. doi: 10.1016/j.chest.2020.07.013
Nataly GC, Rayana FC. Alterações pulmonares causadas pelo novo Coronavírus (COVID-19) e o uso da ventilação mecânica não invasiva. J Health Biol Sci. 2020;8(1):1-3. doi: 10.12662/2317-3076jhbs.v8i1.3185.p1-3.2020
Kaya AG, Öz M, Erol S, Çiftçi F, Çiledağ A, Kaya A. High flow nasal cannula in COVID-19: a literature review. Tuberk Toraks. 2020;62(2):168-74. doi: 10.5578/tt.69807
González-Castro A, Fajardo CA, Medina A, Modesto AV. Ventilación mecánica no invasiva y oxigenoterapia de alto flujo en la pandemia COVID-19: El valor de un empate. Med Intensiva. 2020;45(5):320-1. doi: 10.1016/j.medin.2020.04.017
Goh KJ, Chai HZ, Ong TH, Sewa DW, Phua GC, Tan QL. Early prediction of high flow nasal cannula therapy outcomes using a modified ROX index incorporating heart rate. J Intensive Care. 2020;41(8):1-14. doi: 10.1186/s40560-020-00458-z
Hempel G, Petroff D, Wrigge H. Noninvasive ventilation during acute respiratory distress syndrome in patients with cancer: what really matters. J Thoracic Dis. 2017;9(8):2224-7. doi: 10.21037/jtd.2017.06.131
Roedl K, Jarczak D, Thasler L, Nierhaus A, Hee G, Kluge S, et al. Mechanical ventilation and mortality among 223 critically ill patients with coronavirus disease 2019: A multicentric study in Germany. Aust Crit Care. 2021;34(2):167-175. doi: 10.1016/j.aucc.2020.10.009
Moreira WC, Martins W. Análise dos fatores associados à mortalidade por COVID-19 em uma cidade de tríplice fronteira. Research, Society and Development. 2022;11(1):1-7. doi: 10.33448/rsd-v11i1.24149
Borges LP, Silva HS, Silva JRS, Guimarães AG. Perfil de mortalidade por COVID-19 durante os primeiros 15 meses da pandemia. Research, Society and Development. 2021;10(16):1-5. doi: 10.33448/rsd-v10i16.23924
Souza IV, Scodro RBL, Siqueira VLD, Cardoso RF, Caleffi-Ferracioli KR. Comorbidades e óbitos por COVID-19 no Brasil. Revista Uningá. 2021;58(4):1-9. doi: 10.46311/2318-0579.58.eUJ4054
Chan JFW, Yuan S, Kok KH, To KKW, Chu H, Yang J. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The Lancet. 2020;395(10223):514-23. doi: 10.1016/S0140-6736(20)30154-9
Organização Mundial da Saúde. Histórico da pandemia de COVID-19 [Internet]. [cited 2022 Jan 17]. Available from: https://www.paho.org/pt/covid19/historico-da-pandemia-covid-19
Sanyaolu1 A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P. Comorbidity and its impact on patients with COVID-19. SN Compr Clin Med. 2020;10(2):1069-76. doi: 10.1007/s42399-020-00363-4
Kang SH, Kim SW, Kim Y, Cho KH, Park JW, Do JY. Association between chronic kidney disease or acute kidney injury and clinical outcomes in COVID-19 patients. J Korean Med Sci. 2020;35(50):1-12. doi: 10.3346/jkms.2020.35.e434
Menga LS, Cese LD, Bongiovanni F, Lombardi G, Michi T, Luciani F, et al. High failure rate of noninvasive oxygenation strategies in critically ill subjects with acute hypoxemic respiratory failure due to COVID-19. Respir Care. 2021;66(5):705-14. doi: 10.4187/respcare.08622
Garner O, Dongarwar D, Salihu HM, Perez JHB, Abrahamc J, McBridea C, et al. Predictors of failure of high flow nasal cannula failure in acute hypoxemic respiratory failure due to COVID-19. Respir Med. 2021;185(8):1-3. doi: 10.1016/j.rmed.2021.106474
Sottocornola SF, Silva RR, Barbosa SJ, Queiroz AGS, Souza RZ, Bulgarelli EMN. Terapia de substituição renal em pacientes acometidos pela Covid-19 em uma Unidade de Terapia Intensiva no interior de Rondônia. Research, Society and Development. 2021;10(17):1-7. doi: 10.33448/rsd-v10i17.23921
Shoukri AM. High flow nasal cannula oxygen and non- invasive mechanical ventilation in management of COVID-19 patients with acute respiratory failure: a retrospective observational study. Egypt J Bronchology. 2021;15(17):1-7. doi: 10.1186/s43168-021-00063-0
Katsuno T, Suzuki M, Hojo M, Terada J, Nakamura K, Suzuki T. Clinical experience with high-flow nasal cannulas for coronavirus disease 2019 patients in Japan. Respir Investig. 2021;59(4):569-572. doi: 10.1016/j.resinv.2021.02.011
Calligaro GL, Lalla U, Audley G, Gina P, Miller MG, Mendelson M. The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study. eClinical Medicine. 2020;28(10):1-9. doi: 10.1016/j.eclinm.2020.100570
Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2
Frat JP, Coudroy R, Marjanovic N, Thille AW. High-flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory failure. Ann Trans Med. 2017;5(14):297-304. doi: 10.21037/atm.2017.06.52
Mei Q, Zhu C, Yang T, Yang Y, Fang X, Pan A. High flow nasal cannula is a good treatment option for COVID-19. Heart Lung. 2020;49(5):444-5. doi: 10.1016/j.hrtlng.2020.03.018
Nair PR, Haritha D, Behera S, Kayina CA, Maitra S, Anand RK, et al. Comparison of high-flow nasal cannula and noninvasive ventilation in acute hypoxemic respiratory failure due to severe COVID-19 Pneumonia. Respir Care. 2021;66(12):1824-30. doi: 10.4187/respcare.0913
Deng L, Lei S, Wang X, Jiang F, Lubarsky DA, Zhang L. Course of illness and outcomes in older COVID-19 patients treated with HFNC: a retrospective analysis. Aging. 2021;13(12):15801-14. doi: 10.18632/aging.203224
Brasil. Ministério da Saúde. Vacinômetro covid-19 [Internet]. 2023. [cited 2023 Jan 18]. Available from: https://infoms.saude.gov.br/extensions/DEMAS_C19_Vacina_v2/DEMAS_C19_Vacina_v2.html
Published
Issue
Section
License
Copyright (c) 2023 Paulo Nixon Cardoso Monteiro, Whelen de Sousa Moreira, Maylla Salete Rocha Santos Chaves, Luana Gabrielle de França Ferreira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors are authorized for non-exclusive distribution of the version of the work published in this journal (eg, publishing in an institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
